The new “2023 Retinal Surgical Device Market Report” focuses on the latest developments in robotic vitrectomy, examines when the technology will most likely become available, and shows which elements of robotic vitrectomy are most likely to be adopted by retina surgeons, by priority. The report summarizes the most likely vitrectomy machine developments that will enable widespread adoption of ophthalmic gene therapy in the future, examines the pros and cons of intraoperative OCT and evaluates its future integration with vitrectomy machines, and looks at 3D visualization systems increasingly being offered by the leading vitrectomy machine providers.
The report thoroughly covers the market competitors in this space – listing a number of companies that already have or will soon launch new vitrectomy machines, and profiling 34 companies, with discussion of their products, strategic market position, background, and outlook.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.